Literature DB >> 11750922

SB-334867-A antagonises orexin mediated excitation in the locus coeruleus.

E M Soffin1, M L Evans, C H Gill, M H Harries, C D Benham, C H Davies.   

Abstract

Electrophysiological recordings from identified noradrenergic locus coeruleus (LC) neurones in rat brain slices have revealed that the orexins can cause direct and reversible depolarisation of the postsynaptic membrane. Whilst it is known that the membrane depolarisation produced by orexin-A can triple the firing rate of spontaneously active LC neurones, quantitative pharmacological analysis that determines the receptor subtype(s) mediating the orexinergic response has not yet been performed. Here we demonstrate that the effects of orexin-A are five-fold more potent than orexin-B on LC neuronal excitability. We show further that the orexin receptor antagonist SB-334867-A inhibits the effects of both agonists with pK(B) values similar to those calculated for human OX1 receptors expressed in CHO cells. Finally, we found no evidence for tonic activation of OX1 receptors in LC noradrenergic neurones despite electron microscopic evidence that orexin terminals directly contact these neurones. These data demonstrate that SB-334867-A is a useful tool compound with which to study the physiology of OX1 receptors.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11750922     DOI: 10.1016/s0028-3908(01)00156-3

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  21 in total

1.  Behavioral correlates of activity in identified hypocretin/orexin neurons.

Authors:  Boris Y Mileykovskiy; Lyudmila I Kiyashchenko; Jerome M Siegel
Journal:  Neuron       Date:  2005-06-02       Impact factor: 17.173

2.  Role of orexin input in the diurnal rhythm of locus coeruleus impulse activity.

Authors:  Heinrich S Gompf; Gary Aston-Jones
Journal:  Brain Res       Date:  2008-06-03       Impact factor: 3.252

Review 3.  Role of orexin in central regulation of gastrointestinal functions.

Authors:  Toshikatsu Okumura; Kaoru Takakusaki
Journal:  J Gastroenterol       Date:  2008-09-20       Impact factor: 7.527

4.  Yohimbine depresses excitatory transmission in BNST and impairs extinction of cocaine place preference through orexin-dependent, norepinephrine-independent processes.

Authors:  Kelly L Conrad; Adeola R Davis; Yuval Silberman; Douglas J Sheffler; Angela D Shields; Sam A Saleh; Namita Sen; Heinrich J G Matthies; Jonathan A Javitch; Craig W Lindsley; Danny G Winder
Journal:  Neuropsychopharmacology       Date:  2012-05-23       Impact factor: 7.853

5.  Orexins induce increased excitability and synchronisation of rat sympathetic preganglionic neurones.

Authors:  Marco van den Top; Matthew F Nolan; Kevin Lee; Peter J Richardson; Ruud M Buijs; Ceri H Davies; David Spanswick
Journal:  J Physiol       Date:  2003-04-17       Impact factor: 5.182

Review 6.  Regulation of breathing and autonomic outflows by chemoreceptors.

Authors:  Patrice G Guyenet
Journal:  Compr Physiol       Date:  2014-10       Impact factor: 9.090

Review 7.  Orexin/Hypocretin and Organizing Principles for a Diversity of Wake-Promoting Neurons in the Brain.

Authors:  Cornelia Schöne; Denis Burdakov
Journal:  Curr Top Behav Neurosci       Date:  2017

8.  Effects of orexin-A on propofol anesthesia in rats.

Authors:  Tetsuro Shirasaka; Tetsu Yonaha; Shin Onizuka; Isao Tsuneyoshi
Journal:  J Anesth       Date:  2010-12-10       Impact factor: 2.078

9.  Orexin/hypocretin and histamine: distinct roles in the control of wakefulness demonstrated using knock-out mouse models.

Authors:  Christelle Anaclet; Régis Parmentier; Koliane Ouk; Gérard Guidon; Colette Buda; Jean-Pierre Sastre; Hidéo Akaoka; Olga A Sergeeva; Masashi Yanagisawa; Hiroshi Ohtsu; Patricia Franco; Helmut L Haas; Jian-Sheng Lin
Journal:  J Neurosci       Date:  2009-11-18       Impact factor: 6.167

10.  Orexin mediates the expression of precipitated morphine withdrawal and concurrent activation of the nucleus accumbens shell.

Authors:  Ruth Sharf; Maysa Sarhan; Ralph J Dileone
Journal:  Biol Psychiatry       Date:  2008-04-18       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.